Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5001 USD | -1.75% | -10.86% | -13.82% |
03-22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
02-29 | An unknown buyer agreed to acquire 39.3% stake in Exicure, Inc. from DGP Co.,Ltd. for KRW 6 billion. | CI |
Business Summary
Number of employees: 7
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Immuno-oncology Therapeutics
100.0
%
| 0 | 100.0 % | 29 | 100.0 % | -6,068.12% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 29 | 100.0 % | -6,068.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Kang
CEO | Chief Executive Officer | 63 | 23/02/23 |
Ji-Young Hwang
DFI | Director of Finance/CFO | 47 | 30/11/22 |
Investor Relations Contact | 47 | - | |
Joshua Miller
AUD | Comptroller/Controller/Auditor | 48 | 31/03/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ji-Young Hwang
DFI | Director of Finance/CFO | 47 | 30/11/22 |
Paul Kang
CEO | Chief Executive Officer | 63 | 23/02/23 |
Hyuk Joon Ko
BRD | Director/Board Member | - | 22/08/23 |
Dongho Lee
BRD | Director/Board Member | - | 20/08/23 |
Hojoon Lee
BRD | Director/Board Member | - | 22/08/23 |
Minhee Eom
BRD | Director/Board Member | - | 25/09/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,648,307 | 4,753,248 ( 54.96 %) | 0 | 54.96 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-13.82% | 4.33M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- XCUR Stock
- Company Exicure, Inc.